Abeona Therapeutics Inc. Common Stock

ABEONASDAQ • USD
ThemeGenomics & Precision Med.›Gene Therapy & Gene Editing
4.35 USD
↘ 0.21 (4.61%)AT CLOSE (03:59 PM EDT)
4.40
↗ 0.05 (1.24%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
4.40
↗ 0.05 (1.24%)
🔴Market: CLOSED

ABEO is currently priced at $4.36. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. ABEO is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Oct 30, 2026.

Open?$4.50
High?$4.53
Low?$4.31
Prev. Close?$4.56
Volume?783.4K
Avg. Volume?1.1M
VWAP?$4.37
Rel. Volume?0.69x
Bid / Ask
Bid?$3.77 × 100
Ask?$5.20 × 100
Spread?$1.43
Midpoint?$4.49
Valuation & Ratios
Market Cap?260.8M
Shares Out?57.2M
Float?47.5M
Float %?83.1%
P/E Ratio?N/A
P/B Ratio?2.04
EPS?-$1.10
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
Themes
Healthcare - Genomics & Precision Medicine›Gene Therapy & Gene EditingBiotech - Drug Development›Rare Disease Therapeutics
Employees
226
Market Cap
260.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.abeonatherapeutics.com
Listed
1980-09-19
Address
6555 CARNEGIE AVE, 4TH FLOOR
CLEVELAND, OH 44103
Phone: 646-813-4701
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
0
Momentum?
52
Short Sent.?
30
Piotroski F-Score?3/9Weak
Altman Z-Score?-3.50Distress
Confidence?62%Moderate
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?36.24%Squeeze Risk
Short Interest?17.2M
Days to Cover?12.7
Free Float47.5M
Avg Daily Volume1.4M
Settlement Date2026-10-15
Financial Health
Current Ratio?6.63Strong
Quick Ratio?6.40Strong
Cash Ratio?2.27Strong
Debt/Equity?0.12Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
73
2.04CHEAP▾
P/S?
Peers
100
S&P
8
10.22HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.7CHEAP▾
EV/Sales?
Peers
100
S&P
15
8.60HIGH▾
Returns & Efficiency
ROE?
S&P
3
-49.1%WEAK▾
ROA?
S&P
3
-35.0%WEAK▾
Cash Flow & Enterprise
FCF?$-81527000
Enterprise Value?$219.5M
Fundamentals ratios updated end of day
MarketsMoversWatchlist